Sign Up to like & get
recommendations!
0
Published in 2017 at "PLoS ONE"
DOI: 10.1371/journal.pone.0188191
Abstract: Aβ-Immunotherapy has long been studied in the treatment of Alzheimer’s disease (AD), but not how other molecules involved in the disease can affect antibody performance. We previously designed an antibody fragment, scFv-h3D6, and showed that…
read more here.
Keywords:
mimetic peptides;
apoj;
scfv h3d6;
h3d6 ... See more keywords